Full text is available at the source.
Abstract
Dulaglutide enhances signaling associated with brain function, while buntanetap reduces levels of proteins linked to Alzheimer's disease.
- Alzheimer's disease may arise from issues with protein management, metabolism, and signaling, affecting memory and learning.
- Dulaglutide is a drug that can cross the blood-brain barrier and may improve brain signaling pathways involved in cognitive function.
- Buntanetap may lower the production of certain proteins that can form harmful aggregates in the brain.
- Both dulaglutide and buntanetap show individual cognitive benefits, but their combined effects on brain health are not yet known.
Simplified